These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17477109)

  • 1. A primer on aldosterone for gynecologists/obstetricians.
    Pitt B
    J Reprod Med; 2007 Feb; 52(2 Suppl):153-8. PubMed ID: 17477109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone in congestive heart failure.
    Weber KT
    N Engl J Med; 2001 Dec; 345(23):1689-97. PubMed ID: 11759649
    [No Abstract]   [Full Text] [Related]  

  • 3. Aldosterone receptor antagonism in heart failure.
    Jennings DL; Kalus JS; O'Dell KM
    Pharmacotherapy; 2005 Aug; 25(8):1126-33. PubMed ID: 16207104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid resistance.
    Geller DS
    Clin Endocrinol (Oxf); 2005 May; 62(5):513-20. PubMed ID: 15853818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A neuroendocrine-immune interface. The immunostimulatory state of aldosteronism.
    Weber KT
    Herz; 2003 Dec; 28(8):692-701. PubMed ID: 14689103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The renin-angiotensin system].
    Hilgers KF
    Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
    [No Abstract]   [Full Text] [Related]  

  • 7. Aldosterone and heart failure: the rest of the story.
    Williams GH
    Heart Fail Rev; 2005 Jan; 10(1):5-6. PubMed ID: 15947885
    [No Abstract]   [Full Text] [Related]  

  • 8. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a broader understanding of aldosterone in congestive heart failure.
    Weber KT; Sun Y; Wodi LA; Munir A; Jahangir E; Ahokas RA; Gerling IC; Postlethwaite AE; Warrington KJ
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):155-63. PubMed ID: 14608519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What purpose does the renin-angiotensin-aldosterone system serve in man?].
    Corvol P; Michel JB
    Rev Prat; 1988 Mar; 38(10):585-92. PubMed ID: 3287582
    [No Abstract]   [Full Text] [Related]  

  • 11. A quick glance at rapid aldosterone action.
    Lösel R; Schultz A; Wehling M
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):137-41. PubMed ID: 15134812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of angiotensin and aldosterone in the pathogenesis of hypertension in insulin-dependent diabetes mellitus?
    Feldt-Rasmussen B; Nørgaard K; Mathiesen ER; Jensen T; Deckert T
    Diabete Metab; 1989; 15(5 Pt 2):311-2. PubMed ID: 2693149
    [No Abstract]   [Full Text] [Related]  

  • 13. A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system.
    Usalan C; Buyukhatipoglu H
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):203-9. PubMed ID: 18372278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aldosterone receptor antagonists].
    Muller O; Firsov D; Seydoux C
    Rev Med Suisse; 2007 May; 3(113):1401-4. PubMed ID: 17645055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biochemical pharmacology of renin inhibitors: implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality.
    Abassi Z; Winaver J; Feuerstein GZ
    Biochem Pharmacol; 2009 Oct; 78(8):933-40. PubMed ID: 19477166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contribution of transgenesis models in discovery of new pharmacological targets in heart failure: aldosterone receptor as an example].
    Latouche C; Jaisser F
    Therapie; 2009; 64(2):81-6. PubMed ID: 19664400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renin-angiotensin-aldosterone system in cardiac insufficiency].
    Ramires JA
    Arq Bras Cardiol; 1990 Aug; 55 Suppl A():A6-7. PubMed ID: 2093306
    [No Abstract]   [Full Text] [Related]  

  • 18. Essential hypertension: is there a role for inflammatory mechanisms?
    Androulakis ES; Tousoulis D; Papageorgiou N; Tsioufis C; Kallikazaros I; Stefanadis C
    Cardiol Rev; 2009; 17(5):216-21. PubMed ID: 19690472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone synthase inhibitors: pharmacological and clinical aspects.
    Jansen PM; van den Meiracker AH; Jan Danser AH
    Curr Opin Investig Drugs; 2009 Apr; 10(4):319-26. PubMed ID: 19337952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone and end-organ damage.
    Marney AM; Brown NJ
    Clin Sci (Lond); 2007 Sep; 113(6):267-78. PubMed ID: 17683282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.